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Streptococcus pneumoniae is a nasopharyngeal commensal that occasionally invades normally sterile sites to cause bloodstream
infection andmeningitis. Although the pneumococcal population structure and evolutionary genetics are well defined, it is not
clear whether pneumococci that cause meningitis are genetically distinct from those that do not. Here, we used whole-genome
sequencing of 140 isolates of S. pneumoniae recovered from bloodstream infection (n 70) and meningitis (n 70) to compare
their genetic contents. By fitting a double-exponential decaying-functionmodel, we show that these isolates share a core of 1,427
genes (95% confidence interval [CI], 1,425 to 1,435 genes) and that there is no difference in the core genome or accessory gene
content from these disease manifestations. Gene presence/absence alone therefore does not explain the virulence behavior of
pneumococci that reach the meninges. Our analysis, however, supports the requirement of a range of previously described viru-
lence factors and vaccine candidates for both meningitis- and bacteremia-causing pneumococci. This high-resolution view sug-
gests that, despite considerable competency for genetic exchange, all pneumococci are under considerable pressure to retain key
components advantageous for colonization and transmission and that these components are essential for access to and survival
in sterile sites.
Streptococcus pneumoniae is estimated to cause almost 15 mil-lion episodes of pneumonia, meningitis, and bloodstream in-
fection in children under five annually, with the highest burden in
sub-Saharan Africa (SSA) (1). An important HIV-related patho-
gen, the pneumococcus is also associated with a significant num-
ber of deaths in HIV-infected African adults (2). Nasopharyngeal
colonization is a prerequisite for pneumococcal disease, which
follows a complex multistep process of bloodstream and less fre-
quently cerebrospinal fluid (CSF) invasion through a combina-
tion of engagement between bacteria and host epithelial and en-
dothelial receptors, cytoskeletal rearrangement and transcytosis,
and infection of migrating phagocytes (3–6). The avoidance of
immune surveillance and the capacity of S. pneumoniae to grow
and survive in the relatively hostile blood andmeningeal compart-
ments facilitate these processes (3, 7). Why some patients develop
pneumococcal bacteremia but not meningitis while in others in-
fections occur in both compartments is uncertain.
Our fundamental understanding of the bacterial mechanisms
that determine these host-pathogen interactions is at best incom-
plete and is supported largely by data from tissue culture models
and animal studies (4, 5, 8). In particular, specific pneumococcal
determinants that explain the tropism of this capsulated bacte-
rium for the brain have been elusive. Whether pneumococci that
cause meningitis are genetically distinct from those that do not is
uncertain. While some pneumococcal capsule serotypes are par-
ticularly associated with invasive pneumococcal diseases (IPD) in
humans (9, 10), each with a different invasive potential, there is
currently no evidence that either the serotypes or sequence types
(STs) that cause bacteremia andmeningitis are distinct (11). Like-
wise, numerous other bacterial molecules have been implicated in
the pathogenesis of pneumococcal meningitis (e.g., phosphoryl-
choline, pneumolysin, pneumococcal surface adhesin A, neur-
aminidase A, and pneumococcal adherence and virulence factor
A), but whether these are absolutely required for meningeal inva-
sion and disease causation remains to be determined. Adaptation
of the pneumococcus to the host environment is facilitated by
mutations and by frequent transfers of genetic material (horizon-
tal gene transfer) between isolates and across bacterial species (12–
14). This genetic variability provides considerable redundancy in
the range of tools available to S. pneumoniae to target host recep-
tors, overcome the mucosal barrier, and survive within the naso-
pharynx (7, 15–17).
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Here, we have used whole-genome sequencing of a large col-
lection of disease-causing isolates to revisit pneumococcalmenin-
gitis in humans.We have specifically identified genes that are uni-
versally present in pneumococci associated with invasive disease
(the pneumococcal core genome) and those that are present only
in some invasive isolates (the pneumococcal accessory genome)
and have investigated the hypothesis that meningitis-causing iso-
lates have a genetic content distinct from isolates associated with
bloodstream infection, which explains their ability to survive in
these hostile host environments.
MATERIALS AND METHODS
Strain selection, DNA extraction, and genome sequencing. S. pneu-
moniae isolates selected for genome sequencing (see Table S1 in the sup-
plementalmaterial) were obtained from theMalawi-Liverpool-Wellcome
Trust Clinical Research Programme (MLW) strain archive. Isolates col-
lected between 2002 and 2008 (n 140) were randomly selected from the
archive isolate database using STATA v 9.2 (StataCorp, College Station,
TX). MLW has conducted externally quality-controlled surveillance for
bacterial meningitis and bloodstream infection at Queen Elizabeth Cen-
tral Hospital, Blantyre, Malawi, for over 15 years (1–3). The inclusion
criteria, culture rate, and laboratory methods have not changed apprecia-
bly over this period. Pneumococcal isolateswere obtained from theCSF of
children and adults wheremeningitis was suspected (n 70) and blood of
children and adults with suspected bloodstream infection but not menin-
gitis (n 70) (1, 3). Children were defined as patients15 years of age.
HIV status was not available for the isolates. Too few paired isolates for a
robust analysis were available and therefore were not used. Likewise, too
few noninvasive isolates from Malawi were available to allow a robust
comparison of noninvasive to invasive (blood/CSF) isolates; therefore
noninvasive isolates were not included in this analysis.
Isolates were grown overnight in Todd-Hewitt broth (Oxoid limited,
Basingstoke, Hampshire, England), and genomic DNA was isolated from
the bacteria using a Wizard genomic DNA purification kit (Promega,
USA; product number A1125). Multiplex library construction, with a
200-bp insertion size and 54-nucleotide (nt) or 108-nt paired-end Illu-
mina sequencing, followed by a third 7-nt tag read, was performed ac-
cording to standard protocols (13, 18). Serotype and sequence type data
were derived from genome sequences using previously described proto-
cols (13). The isolates used in the study were anonymized. These data are
published with the approval of the University of Malawi College of Med-
icine Research & Ethics Committee and conform to institutional guide-
lines.
Assembly of draft genomes and annotation. De novo assembly of
draft genome sequences was achieved from multiplexed Illumina se-
quence data as previously described (13, 18). Briefly, assemblies were
made using Velvet v 0.7.03 (19). Velvet was optimized to run with the
longest k-mer that gave an expected coverage value above 20 (13). The
draft genome assemblies were ordered against the S. pneumoniae ATCC
700669 genome (see Table S2 in the supplemental material) using
ABACAS (20) and ACT (21). Coding sequences (CDS) were identified
using Glimmer3 (22).
Genome clustering and core genome analysis. Gene annotations
from 12 publicly available, complete, fully annotated reference genomes
(see Table S2 in the supplementalmaterial) were transferred onto theCDS
in the draft genomes usingRATT (23). Annotated geneswere translated to
protein sequences and assigned to orthologous gene “clusters” using
tribeMCL (24) with default parameters (BLASTP E value cutoff of 1e5
and inflation index of 4) (full details of the clustering pipeline can be
found at https://github.com/fy2/pneumoscript). The OrthoMCL output
was used to establish the core genome for the data sets.
The tribeMCL ortholog clusters were organized into a matrix of ge-
nome content using bespoke Perl scripts, with orthologs from the same
genome arranged in columns and rows identifying annotated orthologs
with similar functions. A blank was inserted where an ortholog was ab-
sent. Genomes (the matrix columns) were randomly sampled in an arith-
metic progression fashion according to the equation SNN/2[2a (N
1)d]. The number of random sampling events, SN, was established using
the least number of genomes under consideration, a (i.e., 1 genome in this
study), the total number of genomes under consideration (i.e., the data set
size),N, and the commondifference of successive genomes, d (i.e., 1) to be
used during sampling. During random sampling, N was initialized as 1
genome for the first event and increased by one unit for each of the sub-
sequent events, until it was equivalent to the total number of genomes in
the data set in the final event. The random genomes were sampled only
once during each event, and the total orthologs shared by all genomes
were counted once for each cluster, thereby excluding paralogous counts.
This was iterated 100 times, resulting in 100 input orders for each event;
the arithmetic average core genome size was computed for each event to
enable the average core genome size to be related to the number of ge-
nomes sampled. Comparisons of core genomes from different data sets
were achieved using Perl scripts and STATA v 9.2 (Stata Corp, College
Station, TX).
Core genome extrapolation. The absolute core genome size was ex-
trapolated by fitting exponentially decaying functions as previously de-
scribed by Tettelin et al. (29). For our data, two distinct decay phases were
identified, so the following double-exponential model was fitted to the
data using the Levenberg-Marquardt iterative estimation method: y kc1 ·
exp(n/tc1) kc2 · exp(n/tc2) gamma. In this model, y is the size of
the core genome, n is the number of sequenced strains, kc1 and tc1 are the
exponent and free parameters, respectively, for the first decay phase, kc2
and tc2 are the exponent and free parameters, respectively, for the second
decay phase, and gamma is the predicted value of the core genome size
with an infinite number of sequenced strains.
RESULTS
The pneumococcal core genome. We first set out to define the
pneumococcal core genome, i.e., those genes that are common to
all human invasive pneumococcal disease isolates. Hiller and col-
leagues have previously undertaken a similar analysis using a data
set of 17 pneumococcal genomes (eight from nasopharyngeal iso-
lates from pediatric patients and nine invasive and avirulent iso-
lates that were publically available). They found that 1,454 gene
clusters (46%) were conserved among all isolates (25). Here, we
have subjected to Illumina sequencing 140 randomly selected in-
vasive pneumococcal isolates, which originate from Malawian
adults and children with meningitis (n 70) or bloodstream in-
fection without clinical meningitis (bacteremia; n 70). TheHIV
status of the individuals from which the isolates were recovered
was not available. These isolates were collected as part of routine
invasive bacterial surveillance at a large teaching hospital in Ma-
lawi (2, 26, 27). The 140 genomes had a mean sequencing read
depth of 155 (minimum depth of 38) (full details of assembly
statistics are listed in Table S4 in the supplemental material). The
isolates belong to different serotypes and clonal types as deter-
mined bymultilocus sequence typing (MLST) (see Table S1 in the
supplemental material) and consequently vary in their previously
reported associationwith invasive disease (28). The genomeswere
first de novo assembled using Velvet v 0.7.03 (19); prediction of
coding sequences and functional annotation were done using
Glimmer3 and RATT (22, 23). A mapping approach, which in-
volves the alignment of query genome sequence reads against a
single reference genome, would not have been be suitable for this
analysis, as mapping highly recombinogenic clones frommultiple
diverse lineages against a single reference genome would consid-
erably restrict the degree of variation detected.
We identified orthologous genes in the assembled genome by
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the process of clustering based on homology. The clustering of
orthologous genes provided a robust basis for comparing and
combining data from multiple diverse genomes. Following clus-
tering, genes from all isolates were divided into three categories:
orthologous genes shared by all isolates (core genes), orthologous
genes shared between two or more isolates (accessory genes), and
genes unique to one isolate. We identified 3,164 orthologous gene
clusters in all 140 isolates. Forty-five percent of the total clusters
(1,428 core genes) were present in all of the study isolates (Fig. 1;
see Table S3 in the supplemental material). Of the remaining clus-
ters, 1,612 (51%) were present in two or more isolates, but not all
isolates, while 124 genes (4%) did not group within a cluster and
were unique to a single isolate. Of the core genes, 1,239/1,428
(87%) could be assigned a definitive function; the remaining 189
core genes (13%) were either of unknown or putative function.
A considerable amount of care was taken to ensure that the
genome assemblies were of good quality and therefore did not
distort the outputs by applying a stringent quality control (QC)
process. Nonetheless, poor assembly of small genomic regions
may have resulted in legitimate core genes being wrongly defined
as accessory genes in our analysis, thus causing us to marginally
underestimate the core genome size. Relaxation of the stringency
to allow for this possibility, whereby a core gene was defined as an
orthologous gene shared by 98% or more isolates, marginally
increased the core genome (the “extended core genome”) size to
1,469 genes. As reported previously, the core genome size was
dependent on the number of isolates used during the analysis and
gradually decreased with the addition of new genomes (Fig. 1A)
but did not reach an absolute plateau, as has been reported in
studies of group B Streptococcus that examined smaller data sets
(29). To ascertain if we had reached a definitive core genome size
for S. pneumoniae, we undertook a decaying-function analysis as
previously described (29). However, instead of a single-exponen-
tial decaying function,we found thatwe could extrapolate the data
until it plateaued with a higher degree of precision by fitting a
double-exponential decaying function (see Fig. S1 in the supple-
mental material). Consistent with the core genome size observed
in our analysis of 140 genomes, we found that, when extrapolated
to infinity using the double-exponential decaying function, the
core genome reached aminimum of 1,427 genes (95% confidence
interval [CI] 1,425 to 1,435 genes; R2 99.6). It can therefore be
concluded that the data set employed in this study allowed us to
accurately assess the core genome content of pneumococci iso-
lated in Malawi.
Composition of the core genome. The core genome common
to all 140 human invasive pneumococcal disease isolates contains
many genes that have been implicated in nasopharyngeal coloni-
zation by inhibiting mucus function, reducing niche competition
by other bacterial species, subverting host cell function, and facil-
itating host cell attachment (Table 1; for a complete list of core
genes see Table S3 in the supplemental material). In animal mod-
els, many of these virulence genes have also been shown to facili-
tate tissue invasion and promote disease. The virulence factors
encoded by the overall core genome identified here include: -ga-
lactosidase (BgaA) and -N-acetylglucosaminidase (StrH), which
deglycosylate mucus glycoconjugate to reduce mucus viscosity,
thereby limitingmucus entrapment and exposing host cell surface
adherence receptors that are exploited by the pneumococcus for
attachment (3, 30), and pyruvate oxidase (SpxB), which catalyzes
the production of hydrogen peroxide, which kills niche competi-
tors to facilitate pneumococcal colonization (8, 15). In view of the
report that serotype 1 patient isolates from the ST217 clonal com-
plex canhave spontaneousmutations in spxB that seem in increase
virulence (4), we investigated allelic variation in the spxB gene in
the data set. We found the SpxB protein to be highly conserved,
andno allelic variants of spxBwere unique to either the bacteremia
or the meningitis isolates.
Also identified in the overall core genomewere genes encoding
virulence proteins that enhance colonization either through bind-
ing host ligands or subverting immune defense, including pneu-
molysin (Ply) (3, 8, 17), autolysin (LytA) (17), choline-binding
protein E (CbpE) (5, 16), pneumococcal adhesion and virulence A
(PavA) (3, 16), and immunoglobulin A1 protease (IgA1 protease).
The overall core genome contains genes that enable niche adapta-
tion and regulation of metabolism in response to alterations in
available carbon sources, cations and amino acids, and anaerobic
conditions (31). These include the formate acetyltransferase gene
(pfl), which is essential for fermentative metabolism. Pfl mutants
have reduced virulence, evidenced by prolonged survival times in
mouse models of bacteremia (31). Fe2 ATP-binding cassette
(ABC) transporters, which are members of the ABC transporter
superfamily, translocating a variety of substrates such as cations,
lipids, and amino acids across membranes (32), have been specif-
ically implicated in pneumococcal virulence (33). Previous PCR-
based studies have shown that several of the associated genes,
while present in all of our invasive isolates, are not always present
in carriage isolates (34, 35). For example, genes encoding NanB
and CbpA have been found to be present in only 81% and 54% of
carriage pneumococci screened, respectively (35). This implies
that carriage isolates encode an alternative set of proteins that aid
colonization, suggesting that there is considerable redundancy in
the range of tools available to the pneumococcus for survival in the
nasopharyngeal niche.
Once the pneumococcus has reached the bloodstream, inva-
sion of the meninges is thought to require a series of genes that
mediate host cell attachment and transcytosis through the blood-
brain barrier (BBB) and then survival within the CSF (3, 4, 8).
Since bacteremia and meningitis are a dead end for the pneumo-
coccus, it is unlikely that these core genes have evolved solely to
facilitate invasion of the brain. We speculate that these core genes
are important for niche survival at the mucosal surface but also
facilitate invasion into and survival in the blood and CSF. Ply
disrupts BBB integrity, PavA facilitates endothelial fibronectin en-
gagement, and Hyl degrades the endothelial extracellular matrix;
in animal models all three of these functions have been strongly
implicated in the pathogenesis of meningitis. We identified a
number of other genes that have been specifically implicated in
pneumococcal meningitis in the overall core genome. These in-
clude genes encoding choline binding protein A (CbpA, SpsA, or
PspC), a member of a family of surface proteins implicated in
colonization (17), which binds to the polymeric immunoglobulin
receptor (pIgR) in order to cross from themucosal surface into the
blood (3, 36). In the absence of pIgR on the surface of brain en-
dothelium, CbpA binds laminin to initiate contact and transloca-
tion across the BBB (3, 4). The core genome also encodes pneu-
mococcal competence proteins (ComA, ComD, ComE, and
ComX), which regulate biofilm formation and are associated with
virulence in animal models of meningitis (30, 37). The promi-
nence of DNA repair and regulation genes in the overall core ge-
nome identified by our analysis suggests the critical nature of gene
The Pneumococcal Core Genome
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FIG 1 Meningitis- and bacteremia-associated pneumococcal core genomes based on 140 invasive isolates. (A) Box and whisker plot of the number of core gene
orthologous clusters observed as the subset of isolates included in the analysis increases, where the subset ranged from 1 to the total number of isolates (n 140).
To generate a subset of isolates, n isolates are randomly selected from the data set. The core genome size is then calculated for n isolates. Each random subset of
a given size is generated 100 times. (B) Box and whisker plot of the number of meningitis and bacteremia core gene orthologous clusters observed as the number
of isolates included in the analysis increases, where the subset ranged from 1 to the total number of isolates (n 70). To generate a subset of isolates, n isolates
are randomly selected from the data set. The core genome size is then calculated for n isolates. Each random subset of a given size is generated 100 times. (C)Map
of the proportion of meningitis-specific core genes in the bacteremia-associated pneumococcal data set (genes present and absent are represented in gray and
white, respectively). A list ofmeningitis-specific proteins is on the x axis, and individual bacteremia-specific isolates with a phylogenetic tree are on the y axis. (D)
Map of the proportion of bacteremia-specific genes in the meningitis-associated pneumococcal data set (genes present and absent are represented in gray and
white, respectively). A list of bacteremia-specific proteins is on the x axis, and individual meningitis isolates with a phylogenetic tree are on the y axis.
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variation for pneumococcal survival in a variety of environments
(12, 38).
Some of the genes identified in the common core genome also
encode putative pneumococcal protein antigen vaccine candi-
dates currently under evaluation (Table 1), with the notable ex-
ception of pilin and NanA, whose genes were not present in the
core genome (3, 8, 17, 39). Other key virulence factors whose
genes were not present in the core genome include pneumococcal
histidine triad protein B (PhtB), pneumococcal histidine triad
protein E (PhtE), pneumococcal surface protein A (PspA), neur-
aminidase A (NanA), neuraminidase C (NanC), pilus subunit A
(RrgA), pilus subunit B (RrgB), pilus subunit C (RrgC), and bac-
teriocin (Blp). Mahdi and colleagues recently conducted a ge-
nome-wide in vivo transcriptomic analysis of pneumococci reach-
ing the brain after murine intranasal infection (40). They
identified a previously uncharacterized protein, alpha-glycero-
FIG 1 continued
The Pneumococcal Core Genome
October 2015 Volume 83 Number 10 iai.asm.org 4169Infection and Immunity
 o
n
 January 7, 2016 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
phosphate oxidase (GlpO), which was substantially upregulated
in brain tissue. GlpO was cytotoxic for human brain microvascu-
lar endothelial cells (HBMECs), and immunization of mice with
GlpO protected against invasive pneumococcal disease. The gene
encoding GlpO was present in the overall core genome (Table 1).
The finding of these putative vaccine candidates in the overall core
genome is especially attractive as it suggests that a vaccine based
on these candidate molecules is likely to be protective against a
wide range of invasive pneumococcal strains.
The core genomes of bloodstream infection and meningitis
pneumococcal isolates. We then conducted separate analyses of
the core genomes of the pneumococcal bloodstream and menin-
gitis subsets to test the hypothesis that there are distinct gene sets
that are absolutely required for invasion, growth, and persistence
in these different niches. The core genomes of the bloodstream
and meningitis subsets were very similar in size (1,457 versus
1,460 genes, respectively) (Fig. 1B). Our analysis identified a sub-
set of 32 genes that were present in the bloodstream core genome
but absent in the meningitis core genome (meningitis-specific
core genes) and a subset of 29 genes that were present in the men-
ingitis core genome but absent in the bloodstream core genome
(bloodstream-specific core genes). However, the genetic differ-
ences identified by this comparative analysis (Fig. 1C and D) were
due to the absence of key genes in just 3/70 (4%) of the blood-
stream isolates (Fig. 1C) and 4/70 (6%) of the meningitis isolates
(Fig. 1D).We found no impact of imbalanced sampling leading to
the dominance of a particular clone or an overrepresentation of
prophage and integrative conjugative elements (ICE) on the re-
sults of the comparative analysis. Therefore, given the known bi-
ological functions of the genes identified and the relatively small
proportion of isolates responsible for the differences, we think it
unlikely that the core genomeofmeningitis-causing pneumococci
is truly distinct from the core genome of bloodstream isolates.
Theaccessory genomesof bloodstream infection andmenin-
gitis pneumococcal isolates. We next compared the accessory
genomes of the bloodstream and meningitis isolates to inter-
rogate the possibility that a large proportion of the blood-
stream isolates possess a subset of accessory genes that were not
present in the meningitis accessory genome (Fig. 2). No acces-
sory gene clusters were composed of only bloodstream or men-
ingitis isolates. Among the accessory gene clusters there was a
strong positive correlation between the number of blood-
stream isolates and the number of meningitis isolates repre-
sented in a cluster (Spearman’s correlation  0.79; P 
0.0001). No accessory genes were more strongly associated
with the bacteremia or meningitis data set.
Factors influencing the pneumococcal core genome. The
pneumococcal isolates analyzedwere randomly selected to avoid a
selection bias, and given the size of the data set, there should be a
clonal balance representative of the invasive strains in circulation.
However, inmany SSA countries, serotype 1 (ST217) accounts for
over 30% of IPD (9, 10), and in our randomly selected Malawian
meningitis data set it accounted for 24% (33/140) of isolates (14
ST217 isolates recovered from blood, 19 isolates recovered from
CSF). It has been suggested that highly virulent serotype 1 pneu-
mococcal isolates have genomic regions associated with pathoge-
nicity that are absent in others that are intermediately virulent or
avirulent (41). Therefore, to address the possibility that “genetic
noise” from the other sequence types (STs) present in the data set
may have masked legitimate differences in the core genome com-
TABLE 1 Summary of key proteins associated with the pneumococcal
core genome
Category Core gene products
Antimicrobial resistance ABC transporter antimicrobial extrusion family
protein, MATE
Multidrug resistance protein, MdtG
Transporters Manganese efflux system, SP1552
ABC transporter, BlpC
Cobalt ABC transporter, CbiO
Virulence factors -Galactosidase, BgaA
BlpC (quorum-sensing pheromone), which
controls Blp
Choline binding protein A, CbpA
Choline binding protein D, CbpD
Choline binding protein E, CbpE
Choline binding protein G, CbpG
Choline binding protein H, CbpH
Competence regulation Competence protein A, ComA
Competence protein D, ComD
Competence protein E, ComE
Competence protein X, ComX
Autolysin, LytA
Cell wall hydrolase, LytB
Cell wall hydrolase, LytC
Neuraminidase, NanB
-N-Acetylglucosaminidase, StrH
Serine/threonine protein kinase
DNA synthesis, repair,
and regulation
Superoxide dismutase, SodA
DNA repair protein, RecN
DNA mismatch protein, RadC
DNA inducible damage protein D
FIG 2 Plot of the number ofmeningitis and bacteremia isolates represented in
each accessory gene cluster. Each circle represents a single gene cluster.
Kulohoma et al.
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position between ST217 causing bacteremia and ST217 causing
CSF invasion, we repeated the above analyses using the ST217
clones alone. The core genomes of the ST217 bloodstream and
meningitis subsets differed in size (1,822 versus 1,795 genes, re-
spectively), and we identified a subset of 42 genes that were pres-
ent in the ST217 bloodstream core genome but absent in the
ST217 meningitis core genome (ST217 meningitis-specific core
genes) and a subset of 15 genes that were present in the ST217
meningitis core genome but absent in the ST217 bloodstream core
genome (ST217 bloodstream-specific core genes). However, as
with the observed core genome differences between the bactere-
mia and meningitis causing isolates in the overall core genome
analysis, the difference in the ST217 core genome sizes was due to
the absence of key genes in only a very small number of isolates.
The 42 core genes that were unique to the ST217 bacteremia iso-
lates were at most absent in 4/19 (21%) of the ST217meningitis
isolates; likewise the 15 core genes that were unique to the ST217
bacteremia isolates were absent in at most 2/14 (14%) of the
ST217 bacteremia isolates. Again, as with the whole data set, we
next compared the accessory genomes of the ST217 meningitis
and bloodstream isolates to assess if a large proportion of the
ST217 meningitis isolates possess a subset of accessory genes that
were not present in the ST217 bloodstream accessory genome.We
found that no ST217 accessory gene clusters consisted only of
bloodstream or meningitis isolates. We observed a positive corre-
lation between the number of ST217 meningitis isolates and the
number of ST217 bloodstream isolates represented in an acces-
sory gene cluster (Spearman’s rank coefficient  0.84; P 
0.0001); this strongly suggests that no ST217 accessory genes were
more strongly associated with a specific invasive disease pheno-
type.
We next carried out the same analysis with all ST217 isolates
excluded and found that there was no difference between the ge-
nome compositions of the bacteremia and meningitis isolates
when ST217 was removed from the data set. The core genomes of
the bacteremia and meningitis isolates, with ST217 excluded,
comprised 1,467 and 1,463 genes, respectively. The 29 bacteremia
“unique” isolates were absent in at most 3/53 (6%) of the men-
ingitis isolates; the meningitis “unique” isolates were absent in at
most of 4/45 (8%) of the bacteremia isolates. We observed a
positive correlation between the number of meningitis isolates
and the number of bloodstream isolates represented in an acces-
sory gene cluster when the ST217 isolates were excluded from the
analysis (Spearman’s rank coefficient  0.92; P  0.0001). This
additional analysis based on subsets of the data set strongly sug-
gests that our initial finding, which reported that there is no dif-
ference in the core genome content between bacteremia andmen-
ingitis S. pneumoniae isolates, is not an artifact of sample bias.
DISCUSSION
Numerous human host factors that determine pneumococcal dis-
ease susceptibility and severity have been identified, including ex-
tremes of age, HIV, splenic dysfunction, sickle cell disease, malig-
nancy, chronic liver disease, malnutrition, and diabetes (42, 43).
In the past our understanding of the bacterial components con-
tributing to disease was largely supported by tissue culturemodels
and animal studies. Here, we have used an innovative bioinfor-
matics approach and a stringent analysis pipeline to interrogate
the pneumococcal genome associated with invasive disease. We
have found, by fitting a double-exponential decaying function,
that disease isolates share a core of 1,427 genes (95% CI, 1,425 to
1,435 genes). The core genome size we report is marginally lower
than the core genome size reported for Streptococcus pneumoniae
by Obert et al. (n 1,553) (44) and Hiller et al. (n 1,454) (25).
However, the reduced core genome size can be explained by the
higher number of isolates and serotypes included in our analyses,
which have likely resulted in greater saturation and amore precise
estimate.
We also show that pneumococci that infect the meninges do
not differ in their core or accessory genome content from those
isolated from the blood, and therefore gene presence/absence
alone does not explain the virulence behavior of some pneumo-
cocci that reach the brain. Although the development of menin-
gitis may simply be a function of bacterial load and time (26,
45–48), the potential effect of more-subtle differences at the
genomic level, specifically allelic variation and gene expression,
requires further investigation. For example, a comparison of the
genomic sequences of four nasopharyngeal PMEN1 isolates and
their capacities to cause disease in a chinchilla otitis media model
revealed allelic differences in Blp regulatory proteins and pneu-
mococcal adherence virulence factor B (PavB) in those isolates
that spread to the brain (49). Gerlini et al. have shown that bacte-
remia is a result of a single pneumococcal clone invading the
blood; this clone then disseminates, and the resulting invasive
pneumococcal population acquires genomic mutations over time
as it adapts to the selective pressures of the bloodstream. It is
feasible that the same behavior is true for meningitis, whereby a
single clone crosses the BBB, proliferates, and rapidly acquires
genomicmutations to permit survival in the CSF (50).Microarray
analysis of pneumococcal gene expression from blood and CSF
infected in vitro has previously identified site-specific patterns of
gene expression (51). Furthermore, host differences identified by
numerous genetic association studies have shown that single nu-
cleotide polymorphisms (SNPs) in innate immunity genes are
linked to an individual’s susceptibility to pneumococcal meningi-
tis. This suggests that specific pneumococcal genotypes may be
able to cause meningitis in some individuals but not others, irre-
spective of the core genome composition and SNP profile of that
genotype (52–54).
A limitation of the study was that it was not possible from the
clinical data available to determine if any of the bacteremia isolates
included in the data set went on to invade the meninges. It is
therefore feasible that some meningitis isolates were incorrectly
assigned as bacteremia isolates. This may have masked subtle dif-
ferences in the accessory genome composition between the bacte-
remia and meningitis isolates, whereby accessory genes that are
more strongly associatedwithmeningitis isolates were found to be
evenly distributed between themeningitis and bacteremia isolates
in our analysis. This, however, will not have affected the overall
core genome composition reported here. It is feasible that the
ability of pneumococci to causemeningitis is dictated by the pres-
ence of a subset of meningitis-specific genes linked through func-
tion and that theremay bemore than one subset combination that
confers the ability to cause meningitis. This hypothesis was not
addressed in the current analysis.
The finding of a repertoire of over 1,400 core genes that are
common to all invasive-disease-causing pneumococci despite the
highly recombinogenic nature of the multiple diverse lineages in-
vestigated provides an important biological insight. The presence
of these core genes and their associated proteins in all disease-
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causing isolates suggests that they are presumably advantageous
for colonization and transmission, as well as being essential for the
pathogen to invade and survive within the bloodstream and me-
ninges. They include a range of previously identified vaccine can-
didate molecules and a number of the core gene clusters (13%)
that could not be assigned a definitive function. The further char-
acterization of these genes together with an assessment of allelic
variation and gene expression amongpneumococci fromdifferent
sites may also reveal important new bacterial housekeeping func-
tions and identify novel candidates that can be exploited as vac-
cine and therapeutic targets.
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